Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)Suresh S. Ramalingam, Claude El Kouri, Román Pérez-Soler et al.|Annals of Oncology|2013Cited by 57
Age as a prognostic factor in small cell lung cancer:a pooled analysis of randomized clinical trials from the Manchester lung cancer group (MLCG) and theUK medical research council clinical trials unit (MRC CTU)Paul Wheatley‐Price, Fiona Blackhall, Elham Sabri et al.|Research Explorer (The University of Manchester)|2013Cited by 0